Shanghai Zhaohong Pharmaceutical

Shanghai Zhaohong Pharmaceutical Technology is a clinical-stage Contract Research Organization (CRO) based in Shanghai, China, providing comprehensive clinical research services to the pharmaceutical and biotechnology sectors. Founded in 2014, the company specializes in clinical trial management (Phase I-IV), bioequivalence (BE) studies, and regulatory affairs, helping clients navigate the complex NMPA approval process. Zhaohong offers a full suite of services including trial design, site monitoring, data management, and medical writing across various therapeutic areas such as oncology, cardiovascular, and metabolic diseases. The firm is positioned as a key partner for both domestic Chinese firms and international companies seeking to conduct clinical trials in the Asia-Pacific region.